Fentanyl test strips are saving lives, but that's just the beginning.

Published Date: 16 Feb 2023

Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.

Read Full News

Latest News

Many Patients With B-Cell Lymphoma Miss Second-Line Care

More than 10% of patients with large B-cell lymphoma may die within a year of starting first-line treatment without ever receiving second-line therapy, a study finds.

How Obesity Affects Operating Room Procedures: Q&A

Surgeons and anesthesiologists need deeper understanding of patient’s background when obesity is at play.

ASGE Guideline: Endoscopic Management of Colonic Strictures

The American Society for Gastrointestinal Endoscopy has issued a broad-ranging update on the management of colonic strictures.

Paediatric e-Scooter Injuries Rising Sharply, Study Finds

Nearly 500 children in England were treated for e-scooter injuries over 6 years, with fewer than 2% wearing a helmet.

Thousands of US Kids Hospitalized for Vitamin Toxicity

Thousands of children have been hospitalized after poisoning by vitamins and minerals in recent years, the majority ingested intentionally.

Irinotecan Fails to Boost Rectal Cancer Outcomes

Adding irinotecan to standard chemoradiotherapy for MRI-defined, locally advanced rectal cancer did not improve disease-free survival or pathologic complete response rates but increased toxicity, including diarrhea and neutropenia.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

More than 10% of patients with large B-cell lymphoma may die within a year of starting first-line treatment without ever receiving second-line therapy, a study finds.

Surgeons and anesthesiologists need deeper understanding of patient’s background when obesity is at play.

The American Society for Gastrointestinal Endoscopy has issued a broad-ranging update on the management of colonic strictures.

Nearly 500 children in England were treated for e-scooter injuries over 6 years, with fewer than 2% wearing a helmet.

Thousands of children have been hospitalized after poisoning by vitamins and minerals in recent years, the majority ingested intentionally.

Adding irinotecan to standard chemoradiotherapy for MRI-defined, locally advanced rectal cancer did not improve disease-free survival or pathologic complete response rates but increased toxicity, including diarrhea and neutropenia.

News All Time

New Steroid May Spare Bone Markers Suppressed by Prednisone

Vamorolone may preserve blood markers of bone and cartilage metabolism that prednisone suppresses in boys treated for Duchenne muscular dystrophy.

Antithrombotics Not Linked to Aneurysm Rupture

In stroke patients with small incidental intracranial aneurysms, standard secondary prevention with antiplatelet or anticoagulant therapy was not linked to increased aneurysm rupture risk over nearly 30 months of follow-up.

Life or Death at 2000 Feet: Flight Nurses Work in Mid-Air

Flight nurses bring the ER with them.

Michigan Reports First US Deaths in Cyclosporiasis Outbreak

A cyclosporiasis outbreak that has grown into the largest on record in the United States has caused its first known deaths, two people in Michigan, the state's health...

Cannabinoid Hyperemesis Syndrome: A Diagnosis of Exclusion

Even the savviest ER Doc is puzzled by Cannabinoid Hyperemesis Syndrome.

Hospitalists Work Brutal Shifts. Here Are New Ways to Cope

Your body is your business in this world. Learn to take care of it so you can take care of your patients.

1 in 8 Hockey Eye Injury Diagnoses Vision-Threatening

US emergency rooms saw an estimated 6466 hockey-related ocular injury cases over a 20-year span, with a notable share being vision-threatening, a recent study shows.

NHS Radiographers Report Rising Racist Abuse

NHS radiographers report a marked rise in racist abuse from patients amid growing anti-immigrant rhetoric, the SoR says.

ROMEO Score Predicts Utility of Echocardiography in Syncope

The ROMEO score accurately identifies adults in the emergency department with syncope or presyncope who are at a low risk for clinically significant echocardiographic findings, a study finds.

Prior Overdoses Spur Carrying Naloxone in Rural Areas

Those who inject drugs or receive treatment for addiction are more likely to carry naloxone.

Routine Lumbar Puncture in Infants Under Review

A risk-stratified management and emerging biomarkers may help reduce unnecessary lumbar punctures and antibiotics while maintaining safety in febrile infants.

Prenatal Opioid Exposure Tied to Vision, ADHD Issues in Kids

A systematic review reveals that prenatal opioid exposure is linked to long-term cognitive deficits, hyperactivity, inattention, and visual impairments in school-aged children.

US FDA Approves First Freeze-dried Plasma Product

The U.S. FDA on Wednesday approved the first freeze-dried plasma product for use in the country, providing an ⁠option for patients when conventional plasma is...

Fitness to Practise Concerns Increase by a Quarter

GMC data show fitness to practise concerns rose 25% in 2025, though 90% failed to meet the threshold for a full investigation.

A&E Waits Hit Over-80s Hardest, Analysis Shows

New Nuffield Trust analysis finds over-80s in England are more than twice as likely as younger patients to face 12-hour A&E waits.

ED-Discharged Current Smokers Open to Cessation Support

Most current smokers discharged from the emergency department who are reached by automated calls express interest in quitting smoking, but only about 1 in 5 accept a Quitline referral, a study finds.

Recommended News For You

Hereditary cancer has a rare and underreported cause.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Therapy Combo Improves Radiographic PFS in Prostate Cancer

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

MRI can save rectal cancer patients from surgery, study suggests

Recommended Articles For You

Lymphomatoid Papulosis: What You Need to Know 

Clinical Pharmacology of Tumor Microenvironment-Activated Prodrugs 

Tumor Ecological Stability and Disease Course Evolution 

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab Combo Boosts R-CHOP in Frontline DLBCL

2.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

3.

The way that miR-377 inhibits cells that cause prostate cancer.

4.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

5.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

1.

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results

2.

Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support

3.

CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review

4.

Iron Deficiency Anemia: Modern Diagnostic Approaches and Personalized Treatment Strategies

5.

Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

3.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot